Published in Autoimmun Rev on February 15, 2005
Cross-priming in health and disease. Nat Rev Immunol (2010) 2.51
Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest (2013) 1.57
Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol (2010) 1.25
The protective effect of intrasplenic transplantation of Ad-IL-18BP/IL-4 gene-modified fetal hepatocytes on ConA-induced hepatitis in mice. PLoS One (2013) 0.92
Antigen specificity of gammadelta T cells depends primarily on the flanking sequences of CDR3delta. J Biol Chem (2009) 0.91
Novel model of antigen-specific induction of bile duct injury. Gastroenterology (2006) 0.84
Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation. Clin Exp Immunol (2012) 0.83
Targeting apoptosis in autoimmune hepatitis. Dig Dis Sci (2014) 0.80
Xenobiotic exposure and autoimmune hepatitis. Hepat Res Treat (2010) 0.80
Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases. PLoS One (2013) 0.80
Failure of CD4 T-cells to respond to liver-derived antigen and to provide help to CD8 T-cells. PLoS One (2011) 0.79
Flanking V and J sequences of complementary determining region 3 of T cell receptor (TCR) δ1 (CDR3δ1) determine the structure and function of TCRγ4δ1. J Biol Chem (2011) 0.77
The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis. PLoS One (2015) 0.77
In situ mass spectrometry of autoimmune liver diseases. Cell Mol Immunol (2011) 0.77
Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study. J Gastroenterol (2010) 0.77
Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia. Exp Hematol (2008) 0.76
Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis. Dig Dis Sci (2010) 0.76
Endogenous n-3 Polyunsaturated Fatty Acids Attenuate T Cell-Mediated Hepatitis via Autophagy Activation. Front Immunol (2016) 0.75
Expression and roles of TIPE2 in autoimmune hepatitis. Exp Ther Med (2017) 0.75
Primary biliary cirrhosis. N Engl J Med (2005) 7.59
Primary biliary cirrhosis. Hepatology (2009) 5.35
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin (2008) 3.58
Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum (2002) 3.30
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study. J Hepatol (2012) 2.91
Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology (2011) 2.64
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology (2004) 2.64
Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe (2008) 2.30
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood (2012) 2.30
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology (2005) 2.17
Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial. Hepatology (2004) 2.16
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Accuracy in measurement of distance using limited cone-beam computerized tomography. Int J Oral Maxillofac Implants (2004) 2.14
Frequency of monosomy X in women with primary biliary cirrhosis. Lancet (2004) 2.13
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology (2007) 2.08
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology (2007) 1.93
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Probiotics and immunity. J Gastroenterol (2009) 1.79
B cell activation regulates exosomal HLA production. Eur J Immunol (2008) 1.78
Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology (2013) 1.78
The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways. PLoS One (2008) 1.76
Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology (2002) 1.72
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (2015) 1.70
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology (2004) 1.67
Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology (2009) 1.65
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology (2009) 1.61
The role of environmental factors in primary biliary cirrhosis. Trends Immunol (2009) 1.61
Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol (2013) 1.57
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev (2009) 1.57
Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives. Am J Gastroenterol (2004) 1.57
Regulatory T cells: development, function and role in autoimmunity. Autoimmun Rev (2005) 1.57
The unfinished business of primary biliary cirrhosis. J Hepatol (2008) 1.56
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Consumption of wild boar linked to cases of hepatitis E. J Hepatol (2004) 1.54
Cytochrome P450 2A6: a new hepatic autoantigen in patients with chronic hepatitis C virus infection. J Hepatol (2003) 1.53
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol (2003) 1.53
Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology (2006) 1.53
Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol (2004) 1.52
The SAPHO syndrome. Semin Arthritis Rheum (2012) 1.50
Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev (2004) 1.50
Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun Rev (2005) 1.48
Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun (2011) 1.48
Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology (2010) 1.47
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol (2005) 1.47
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology (2003) 1.46
Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology (2008) 1.45
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol (2005) 1.41
A dietary restriction influences the progression but not the initiation of MSG-Induced nonalcoholic steatohepatitis. J Med Food (2014) 1.41
Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun (2009) 1.41
The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol (2013) 1.41
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun (2006) 1.41
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology (2008) 1.40
Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int (2014) 1.40
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int (2006) 1.40
The retroviral myth of primary biliary cirrhosis: is this (finally) the end of the story? J Hepatol (2009) 1.39
Apocalypsal versus apocryphal: the role of retroviruses in primary biliary cirrhosis. Am J Gastroenterol (2004) 1.39
Disparities in hepatocellular carcinoma survival among Californians of Asian ancestry, 1988 to 2007. Cancer Epidemiol Biomarkers Prev (2010) 1.38
Primary biliary cirrhosis. Lancet (2011) 1.37
Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology (2005) 1.37
The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun (2007) 1.36
Lupus nephritis: a critical review. Autoimmun Rev (2012) 1.36
Is autoimmunity a matter of sex? Autoimmun Rev (2008) 1.35
Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology (2009) 1.34
Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev (2008) 1.33
Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev (2010) 1.33
Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology (2013) 1.33
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. Am J Hum Genet (2012) 1.32
Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) (2004) 1.32
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet (2012) 1.32
Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology (2008) 1.30
Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology (2005) 1.28
The implications of autoimmunity and pregnancy. J Autoimmun (2009) 1.28
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev (2012) 1.26
The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun (2008) 1.25
The consequences of apoptosis in autoimmunity. J Autoimmun (2008) 1.24
The X chromosome and immune associated genes. J Autoimmun (2011) 1.24
Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun (2009) 1.24
The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun (2008) 1.24
Characteristics of accessory mental foramina observed on limited cone-beam computed tomography images. J Endod (2008) 1.24